"Chemokine CCL20" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC-type chemokine with specificity for CCR6 RECEPTORS. It has activity towards DENDRITIC CELLS; T-LYMPHOCYTES; and B-LYMPHOCYTES.
| Descriptor ID |
D054418
|
| MeSH Number(s) |
D12.644.276.374.200.110.880 D12.644.276.374.200.600.880 D12.776.467.374.200.110.880 D12.776.467.374.200.600.880 D23.125.300.110.880 D23.125.300.600.880 D23.469.200.110.880 D23.469.200.600.880 D23.529.374.200.110.880 D23.529.374.200.600.880
|
| Concept/Terms |
Chemokine CCL20- Chemokine CCL20
- CCL20, Chemokine
- Exodus-1 Chemokine
- Chemokine, Exodus-1
- Exodus 1 Chemokine
- Small Inducible Cytokine A20
- MIP-3-alpha
- SCYA20 Chemokine
- Chemokine, SCYA20
- CCL20 Chemokine
- Chemokine, CCL20
- Macrophage Inflammatory Protein 3 alpha
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL20".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL20".
This graph shows the total number of publications written about "Chemokine CCL20" by people in this website by year, and whether "Chemokine CCL20" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2008 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 3 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL20" by people in Profiles.
-
PPARd dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment. Gastric Cancer. 2023 Nov; 26(6):904-917.
-
Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation. Int J Mol Sci. 2020 Jul 31; 21(15).
-
Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183. Artif Cells Nanomed Biotechnol. 2019 Dec; 47(1):4038-4045.
-
PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in Mice. Gastroenterology. 2019 07; 157(1):163-178.
-
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol. BMC Cancer. 2018 02 13; 18(1):187.
-
Fusobacterium Nucleatum Subspecies Animalis Influences Proinflammatory Cytokine Expression and Monocyte Activation in Human Colorectal Tumors. Cancer Prev Res (Phila). 2017 Jul; 10(7):398-409.
-
Interferon-gamma deficiency protects against aging-related goblet cell loss. Oncotarget. 2016 10 04; 7(40):64605-64614.
-
Isolation, characterization, and functional analysis of ferret lymphatic endothelial cells. Vet Immunol Immunopathol. 2015 Feb 15; 163(3-4):134-45.
-
The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Invest Ophthalmol Vis Sci. 2013 Jun 12; 54(6):4081-91.
-
Functional characterization of ferret CCL20 and CCR6 and identification of chemotactic inhibitors. Cytokine. 2013 Mar; 61(3):924-32.